Literature DB >> 15535422

Increasing prevalence of HIV-1 reverse transcriptase mutation K65R correlates with tenofovir utilization.

Ron M Kagan, Thomas C Merigan, Mark A Winters, Peter N R Heseltine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15535422

Source DB:  PubMed          Journal:  Antivir Ther        ISSN： 1359-6535


× No keyword cloud information.
  4 in total

1.  Decreasing population selection rates of resistance mutation K65R over time in HIV-1 patients receiving combination therapy including tenofovir.

Authors:  K Theys; J Snoeck; J Vercauteren; A B Abecasis; A-M Vandamme; R J Camacho
Journal:  J Antimicrob Chemother       Date:  2012-09-30       Impact factor: 5.790

2.  The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations.

Authors:  Urvi M Parikh; Lee Bacheler; Dianna Koontz; John W Mellors
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitors.

Authors:  Nicolas Sluis-Cremer; Chih-Wei Sheen; Shannon Zelina; Pedro S Argoti Torres; Urvi M Parikh; John W Mellors
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

4.  Evaluating the impact of antiretroviral and antiseizure medication interactions on treatment effectiveness among outpatient clinic attendees with HIV in Zambia.

Authors:  Allison Navis; Ifunanya Dallah; Charles Mabeta; Kalo Musukuma; Omar K Siddiqi; Christopher M Bositis; Igor J Koralnik; Harris A Gelbard; William H Theodore; Jason F Okulicz; Brent A Johnson; Izukanji Sikazwe; David R Bearden; Gretchen L Birbeck
Journal:  Epilepsia       Date:  2020-10-21       Impact factor: 5.864
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.